A large study published in The BMJ on July 22 reported that adults with type 2 diabetes taking GLP-1 medicines such as semaglutide were more likely to be diagnosed with hair loss than those on other diabetes drugs
Changes in Hydration Habits Hydration patterns may also change while using GLP-1 medications
What the Data Shows The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, randomized 2,539 adults with obesity to tirzepatide at 5, 10, or 15 mg weekly or placebo for 72 weeks (3)
Thymosin Alpha-1 has more clinical backing, with published trials in immunomodulation and hepatitis treatment, yet it remains investigational in most jurisdictions
The study was conducted using data obtained from the TriNetX global health research network, which operates under a waiver of informed consent granted by the Western Institutional Review Board because all records are de-identified
Common side effects include nausea, feeling full sooner, and mild abdominal discomfort